Ameriprise
SLXP

Ameriprise’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Ameriprise’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-367,887
Closed -$63.6M – 4167
2015
Q1 		$63.6M Sell
367,887
-23,572
-6% -$3.46M 0.04% 451
2014
Q4 		$45M Sell
391,459
-654,609
-63% -$79.3M 0.03% 552
2014
Q3 		$163M Sell
1,046,068
-699,170
-40% -$101M 0.1% 217
2014
Q2 		$215M Buy
1,745,238
+50,977
+3% +$5.63M 0.13% 174
2014
Q1 		$176M Sell
1,694,261
-362,789
-18% -$37.1M 0.11% 204
2013
Q4 		$185M Sell
2,057,050
-28,887
-1% -$2.3M 0.11% 211
2013
Q3 		$140M Buy
2,085,937
+228,058
+12% +$15.7M 0.09% 247
2013
Q2 		$123M Buy
+1,857,879
New +$106M 0.09% 263

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Ameriprise's SLXP Position: Q2 2015 in Review

Ameriprise sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 367,887 shares — an estimated $63.6M sold.

Ameriprise first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $215M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Ameriprise reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Ameriprise sold 367,887 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $63.6M.
  • Ameriprise first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Ameriprise's SALIX PHARMACEUTICALS LTD DEL position peaked at $215M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Ameriprise's 13F filing for Q2 2015, filed 13 Aug 2015.